The Lancet

Microbiota therapies

Cover illustration for The Lancet Gastroenterology & Hepatology, Volume 9, Issue 5.

Brief: Current microbiota therapies (FTM) present some risks (e.g., transmission of diseases or infections), so efforts are being made to develop «artificial» therapies with the same microbes and FTM products, but grown in the laboratory.

AD | Hugh Thomas, Rob Brierley & Team.